{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:40:10Z","timestamp":1791895210747,"version":"4.3.4"},"reference-count":128,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Wroclaw Medical University","award":["SUBK.D130.22.055"],"award-info":[{"award-number":["SUBK.D130.22.055"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>People with Down syndrome (PWDS) are more at risk for developing obesity, oxidative stress disorders, metabolic disorders, and lipid and carbohydrate profile disorders than the general population. The presence of an additional copy of genes on chromosome 21 (i.e., the superoxide dismutase 1 gene (SOD1) and gene coding for the cystathionine \u03b2-synthase (CBS) enzyme) raises the risk for cardiovascular disease (CVD). As a result of disorders in metabolic processes and biochemical pathways, theoretically protective factors (low homocysteine level, high SOD1 level) do not fulfil their original functions. Overexpression of the CBS gene leads to the accumulation of homocysteine\u2014a CVD risk factor. An excessive amount of protective SOD1, in the case of a lack of compensatory increase in the activity of catalase and peroxidase, leads to intensifying free radical processes. The occurrence of metabolic disorders and the amplified effect of oxidative stress carries higher risk of exposure of people with DS to CVD. At present, classic predispositions are known, but it is necessary to identify early risk factors in order to be able to employ CVD and obesity prophylaxis. Detailed determination of the metabolic and lipid profile may provide insight into the molecular mechanisms underlying CVD.<\/jats:p>","DOI":"10.3390\/biomedicines10123219","type":"journal-article","created":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T04:05:22Z","timestamp":1670817922000},"page":"3219","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Pediatric Population with Down Syndrome: Obesity and the Risk of Cardiovascular Disease and Their Assessment Using Omics Techniques\u2014Review"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9051-4296","authenticated-orcid":false,"given":"Marta","family":"Hetman","sequence":"first","affiliation":[{"name":"Department of Basic Medical Sciences, Wroclaw Medical University, 50-556 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Barg","sequence":"additional","affiliation":[{"name":"Department of Basic Medical Sciences, Wroclaw Medical University, 50-556 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,12,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/cem.941","article-title":"Symbiosis of Chemometrics and Metabolomics: Past, Present, and Future","volume":"19","author":"Smilde","year":"2005","journal-title":"J. Chemom."},{"key":"ref_2","unstructured":"World Health Organization (WHO) (2018). International Classification of Functioning, Disability and Health, World Health Organization."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1056\/NEJMra1706537","article-title":"Down Syndrome","volume":"382","author":"Bull","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_4","first-page":"86","article-title":"Prevalence of Common Disease Conditions in a Large Cohort of Individuals with down Syndrome in the United States","volume":"8","author":"Chicoine","year":"2021","journal-title":"J. Patient-Cent. Res. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1365-2788.2009.01158.x","article-title":"Down Syndrome: A Cardiovascular Perspective","volume":"53","author":"Vis","year":"2009","journal-title":"J. Intellect. Disabil. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1300\/J083v38n01_03","article-title":"Barriers and Supports for Exercise Participation among Adults with down Syndrome","volume":"38","author":"Heller","year":"2003","journal-title":"J. Gerontol. Soc. Work."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Castro-Pi\u00f1ero, J., Carbonell-Baeza, A., Martinez-Gomez, D., G\u00f3mez-Mart\u00ednez, S., Cabanas-S\u00e1nchez, V., Santiago, C., Veses, A.M., Bandr\u00e9s, F., Gonzalez-Galo, A., and Gomez-Gallego, F. (2014). Follow-up in Healthy Schoolchildren and in Adolescents with down Syndrome: Psycho-Environmental and Genetic Determinants of Physical Activity and Its Impact on Fitness, Cardiovascular Diseases, Inflammatory Biomarkers and Mental Health; the Up & Down Study. BMC Public Health, 14.","DOI":"10.1186\/1471-2458-14-400"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e1382","DOI":"10.1542\/peds.2011-1262","article-title":"Lipid Profiles of Children with down Syndrome Compared with Their Siblings","volume":"129","author":"Adelekan","year":"2012","journal-title":"Pediatrics"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.dhjo.2013.09.003","article-title":"Health Outcome Disparities among Subgroups of People with Disabilities: A Scoping Review","volume":"7","author":"Rowland","year":"2014","journal-title":"Disabil. Health J."},{"key":"ref_10","first-page":"629","article-title":"Metabolomics in medical sciences and trends, challenges and perspectives","volume":"72","author":"Kokot","year":"2015","journal-title":"Acta Pol. Pharm. Drug Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1080\/004982599238047","article-title":"\u201cMetabonomics\u201d: Understanding the Metabolic Responses of Living Systems to Pathophysiological Stimuli via Multivariate Statistical Analysis of Biological NMR Spectroscopic Data","volume":"29","author":"Nicholson","year":"1999","journal-title":"Xenobiotica"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/eurheartj\/ehs092","article-title":"European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) the Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by Representatives of Nine Societies and by Invited Experts)Developed with the Special Contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)","volume":"33","author":"Perk","year":"2012","journal-title":"Eur. Heart J."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Inouye, M., Ripatti, S., Kettunen, J., Lyytik\u00e4inen, L.-P., Oksala, N., Laurila, P.-P., Kangas, A.J., Soininen, P., Savolainen, M.J., and Viikari, J. (2012). Novel Loci for Metabolic Networks and Multi-Tissue Expression Studies Reveal Genes for Atherosclerosis. PLoS Genet., 8.","DOI":"10.1371\/journal.pgen.1002907"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/eurheartj\/ehr158","article-title":"ESC\/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)","volume":"32","author":"Reiner","year":"2011","journal-title":"Eur. Heart J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1161\/CIRCULATIONAHA.109.912568","article-title":"Assessing the Role of Circulating, Genetic, and Imaging Biomarkers in Cardiovascular Risk Prediction","volume":"123","author":"Wang","year":"2011","journal-title":"Circulation"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1093\/eurheartj\/eht301","article-title":"Stabilization of Atherosclerotic Plaques: An Update","volume":"34","author":"Bentzon","year":"2013","journal-title":"Eur. Heart J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/msb.2010.93","article-title":"Metabonomic, Transcriptomic, and Genomic Variation of a Population Cohort","volume":"6","author":"Inouye","year":"2010","journal-title":"Mol. Syst. Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1161\/CIRCULATIONAHA.111.060368","article-title":"Metabolomic Profiling for the Identification of Novel Biomarkers and Mechanisms Related to Common Cardiovascular Diseases","volume":"126","author":"Shah","year":"2012","journal-title":"Circulation"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1093\/eurheartj\/ehs020","article-title":"High-Throughput Quantification of Circulating Metabolites Improves Prediction of Subclinical Atherosclerosis","volume":"33","author":"Wurtz","year":"2012","journal-title":"Eur. Heart J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jvs.2013.06.007","article-title":"Intestinal Microbial Metabolism of Phosphatidylcholine and Cardiovascular Risk","volume":"58","author":"Tang","year":"2013","journal-title":"J. Vasc. Surg."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1039\/b418288j","article-title":"Measuring the Metabolome: Current Analytical Technologies","volume":"130","author":"Dunn","year":"2005","journal-title":"Analyst"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1161\/CIRCRESAHA.113.302095","article-title":"Cardiac Metabolism and Its Interactions with Contraction, Growth, and Survival of Cardiomyocytes","volume":"113","author":"Kolwicz","year":"2013","journal-title":"Circ. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jpba.2015.04.021","article-title":"Metabolomics in Cardiovascular Diseases","volume":"113","author":"Kordalewska","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/clinchem\/37.3.377","article-title":"Quantification of Plasma Lipoproteins by Proton Nuclear Magnetic Resonance Spectroscopy","volume":"37","author":"Otvos","year":"1991","journal-title":"Clin. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nrcardio.2011.138","article-title":"Metabolomics as a Tool for Cardiac Research","volume":"8","author":"Griffin","year":"2011","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e000032","DOI":"10.1161\/HCG.0000000000000032","article-title":"Potential Impact and Study Considerations of Metabolomics in Cardiovascular Health and Disease: A Scientific Statement from the American Heart Association","volume":"10","author":"Cheng","year":"2017","journal-title":"Circ. Cardiovasc. Genet."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3898502","DOI":"10.1155\/2016\/3898502","article-title":"Metabolomics and Type 2 Diabetes: Translating Basic Research into Clinical Application","volume":"2016","author":"Klein","year":"2016","journal-title":"J. Diabetes Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1210\/jc.2015-3525","article-title":"Lipidomics Reveals Associations of Phospholipids with Obesity and Insulin Resistance in Young Adults","volume":"101","author":"Rauschert","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"5053","DOI":"10.1038\/s41598-019-41449-x","article-title":"An Individual Participant Data Meta-Analysis on Metabolomics Profiles for Obesity and Insulin Resistance in European Children","volume":"9","author":"Hellmuth","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1159\/000365037","article-title":"Rapid Growth and Childhood Obesity Are Strongly Associated with LysoPC (14:0)","volume":"64","author":"Rzehak","year":"2014","journal-title":"Ann. Nutr. Metab."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/ijo.2008.89","article-title":"Serum Phospholipid and Cholesteryl Ester Fatty Acids and Estimated Desaturase Activities Are Related to Overweight and Cardiovascular Risk Factors in Adolescents","volume":"32","author":"Steffen","year":"2008","journal-title":"Int. J. Obes."},{"key":"ref_32","first-page":"927","article-title":"Atherosclerosis: Process, Indicators, Risk Factors and New Hopes","volume":"5","author":"Setorki","year":"2014","journal-title":"Int. J. Prev. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1055\/s-0037-1614438","article-title":"Hyperhomocysteinemia, Atherosclerosis and Thrombosis","volume":"81","author":"Cattaneo","year":"1999","journal-title":"Thromb. Haemost."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1161\/CIRCULATIONAHA.114.013116","article-title":"Metabolite Profiling and Cardiovascular Event Risk","volume":"131","author":"Havulinna","year":"2015","journal-title":"Circulation"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.atherosclerosis.2013.10.036","article-title":"Validation of the Association between a Branched Chain Amino Acid Metabolite Profile and Extremes of Coronary Artery Disease in Patients Referred for Cardiac Catheterization","volume":"232","author":"Bhattacharya","year":"2014","journal-title":"Atherosclerosis"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e13384","DOI":"10.1111\/obr.13384","article-title":"A Systematic Review of Metabolomic Studies of Childhood Obesity: State of the Evidence for Metabolic Determinants and Consequences","volume":"23","author":"Handakas","year":"2021","journal-title":"Obes. Rev."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Polidori, N., Grasso, E.A., Chiarelli, F., and Giannini, C. (2022). Amino Acid-Related Metabolic Signature in Obese Children and Adolescents. Nutrients, 14.","DOI":"10.3390\/nu14071454"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1126\/science.111.2877.166","article-title":"The Role of Lipids and Lipoproteins in Atherosclerosis","volume":"111","author":"Gofman","year":"1950","journal-title":"Science"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-800177-6.00001-3","article-title":"Lipidomics Applications for Discovering Biomarkers of Diseases in Clinical Chemistry","volume":"313","author":"Zhao","year":"2014","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/MED.0000000000000704","article-title":"Lipidomics in Diabetes","volume":"29","author":"Kim","year":"2021","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/bmj.2.6081.226","article-title":"Down\u2019s Syndrome: An Atheroma-Free Model?","volume":"2","author":"Murdoch","year":"1977","journal-title":"BMJ"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2788.1992.tb00535.x","article-title":"Lipids and Lipoproteins in Persons with Down\u2019s Syndrome","volume":"36","author":"Pueschel","year":"2008","journal-title":"J. Intellect. Disabil. Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/dmcn.12868","article-title":"Morbidity and Medication in a Large Population of Individuals with down Syndrome Compared to the General Population","volume":"58","author":"Alexander","year":"2015","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Sobey, C.G., Judkins, C.P., Sundararajan, V., Phan, T.G., Drummond, G.R., and Srikanth, V.K. (2015). Risk of Major Cardiovascular Events in People with down Syndrome. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0137093"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1365-2788.1992.tb00534.x","article-title":"Prevalence of Overweight and Obesity in Down\u2019s Syndrome and Other Mentally Handicapped Adults Living in the Community","volume":"36","author":"Bell","year":"2008","journal-title":"J. Intellect. Disabil. Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1365-2788.1995.tb00548.x","article-title":"Overweight and Obesity amongst Down\u2019s Syndrome Adults","volume":"39","author":"Prasher","year":"1995","journal-title":"J. Intellect. Disabil. Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1365-2788.2004.00616.x","article-title":"Obesity in Adults with down Syndrome: A Case-Control Study","volume":"49","author":"Melville","year":"2005","journal-title":"J. Intellect. Disabil. Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0009-8981(84)90267-5","article-title":"Cholesterol Fractions and Triglycerides in Children and Adults with Down\u2019s Syndrome","volume":"142","author":"Gaethke","year":"1984","journal-title":"Clin. Chim. Acta"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e20190137","DOI":"10.1542\/peds.2019-0137","article-title":"Cardiometabolic Risk and Body Composition in Youth with down Syndrome","volume":"144","author":"Magge","year":"2019","journal-title":"Pediatrics"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0140-6736(87)91772-7","article-title":"Does down Syndrome Support Homocysteine Theory of Arteriosclerosis?","volume":"329","author":"Englund","year":"1987","journal-title":"Lancet"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0021-9150(89)90110-X","article-title":"Down\u2019s Syndrome and Atherosclerosis","volume":"76","author":"Luoma","year":"1989","journal-title":"Atherosclerosis"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.amjcard.2010.06.079","article-title":"Comparison of Intima-Media Thickness of the Carotid Artery and Cardiovascular Disease Risk Factors in Adults with versus without the down Syndrome","volume":"106","author":"Draheim","year":"2010","journal-title":"Am. J. Cardiol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/jch.12890","article-title":"Atherosclerotic Surrogate Markers in Adults with down Syndrome: A Case-Control Study","volume":"19","author":"Parra","year":"2016","journal-title":"J. Clin. Hypertens."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.archger.2007.10.011","article-title":"Adipocytokines in Down\u2019s Syndrome, an Atheroma-Free Model: Role of Adiponectin","volume":"48","author":"Corsi","year":"2009","journal-title":"Arch. Gerontol. Geriatr."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s40478-017-0499-4","article-title":"Cerebrovascular Pathology in down Syndrome and Alzheimer Disease","volume":"5","author":"Head","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7322\/jhgd.v30.9968","article-title":"Lipid Profile in People with down Syndrome: A Literature Review","volume":"30","author":"Greguol","year":"2020","journal-title":"J. Hum. Growth Dev."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2147\/VHRM.S21273","article-title":"Stiffness of the Large Arteries in Individuals with and without down Syndrome","volume":"7","author":"Rodrigues","year":"2011","journal-title":"Vasc. Health Risk Manag."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"100947","DOI":"10.1016\/j.dhjo.2020.100947","article-title":"Cause of Death in Adults with down Syndrome in the United States","volume":"13","author":"Landes","year":"2020","journal-title":"Disabil. Health J."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1001\/archinte.163.6.705","article-title":"Mortality and Cancer Incidence among Individuals with down Syndrome","volume":"163","author":"Hill","year":"2003","journal-title":"Arch. Intern. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1469-8749.2005.tb01111.x","article-title":"Mortality and Causes of Death in Persons with down Syndrome in California","volume":"47","author":"Day","year":"2007","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1046\/j.1469-1809.2001.6520167.x","article-title":"Mortality and Cancer Incidence in Persons with Down\u2019s Syndrome, Their Parents and Siblings","volume":"65","author":"Hermon","year":"2001","journal-title":"Ann. Hum. Genet."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ejmg.2016.06.005","article-title":"Lipid Profiles in a Large Cohort of Italian Children with down Syndrome","volume":"59","author":"Buonuomo","year":"2016","journal-title":"Eur. J. Med. Genet."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1253\/circj.CJ-20-0051","article-title":"Lipoprotein(A) and Cardiovascular Diseases Revisited","volume":"84","author":"Jang","year":"2020","journal-title":"Circ. J."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Krzesi\u0144ska, A., K\u0142osowska, A., Sa\u0142aga-Zaleska, K., \u0106wikli\u0144ska, A., Mickiewicz, A., Chy\u0142a, G., Wierzba, J., Jankowski, M., and Kuchta, A. (2022). Lipid Profile, Lp(A) Levels, and HDL Quality in Adolescents with down Syndrome. J. Clin. Med., 11.","DOI":"10.3390\/jcm11154356"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1194\/jlr.C079111","article-title":"Lipoprotein(A): The Common, Likely Causal, yet Elusive Risk Factor for Cardiovascular Disease","volume":"58","author":"Kamstrup","year":"2017","journal-title":"J. Lipid Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1001\/jamacardio.2020.5398","article-title":"Clinical Utility of Lipoprotein(A) and LPA Genetic Risk Score in Risk Prediction of Incident Atherosclerotic Cardiovascular Disease","volume":"6","author":"Trinder","year":"2021","journal-title":"JAMA Cardiol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/S0140-6736(03)12987-X","article-title":"Down\u2019s Syndrome","volume":"361","author":"Roizen","year":"2003","journal-title":"Lancet"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1053\/jada.2003.50025","article-title":"Prevalence of Obesity in International Special Olympic Athletes as Determined by Body Mass Index","volume":"103","author":"Harris","year":"2003","journal-title":"J. Am. Diet. Assoc."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S2352-4642(19)30400-6","article-title":"Nutritional Challenges in Children and Adolescents with down Syndrome","volume":"4","author":"Hope","year":"2020","journal-title":"Lancet Child Adolesc. Health"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ridd.2016.06.018","article-title":"Overweight and Obesity in Children and Adolescents with down Syndrome\u2014Prevalence, Determinants, Consequences, and Interventions: A Literature Review","volume":"57","author":"Bertapelli","year":"2016","journal-title":"Res. Dev. Disabil."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/S0002-8223(96)00330-6","article-title":"Nutrient Intake and Obesity in Prepubescent Children with down Syndrome","volume":"96","author":"Luke","year":"1996","journal-title":"J. Am. Diet. Assoc."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1542\/peds.2011-1605","article-title":"Health Supervision for Children with down Syndrome","volume":"128","author":"Bull","year":"2011","journal-title":"Pediatrics"},{"key":"ref_73","first-page":"s176","article-title":"Obesity: Definition, comorbidities, causes, and burden","volume":"22","author":"Apovian","year":"2016","journal-title":"Am. J. Manag. Care"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.apmr.2004.10.038","article-title":"Obesity Prevalence among a Group of Chicago Residents with Disabilities","volume":"86","author":"Rimmer","year":"2005","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"4395","DOI":"10.1016\/j.ridd.2013.09.021","article-title":"Accelerometer-Determined Physical Activity and Walking Capacity in Persons with down Syndrome, Williams Syndrome and Prader\u2013Willi Syndrome","volume":"34","author":"Hansen","year":"2013","journal-title":"Res. Dev. Disabil."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/jar.12416","article-title":"Do Adults with down Syndrome Do the Same Amount of Physical Activity as Adults without Disability? A Proof of Principle Study","volume":"31","author":"Shields","year":"2017","journal-title":"J. Appl. Res. Intellect. Disabil."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/PEP.0000000000000556","article-title":"Physical Activity Levels of Children with down Syndrome","volume":"31","author":"Fox","year":"2019","journal-title":"Pediatr. Phys. Ther."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Hsieh, K., Hilgenkamp, T., Murthy, S., Heller, T., and Rimmer, J. (2017). Low Levels of Physical Activity and Sedentary Behavior in Adults with Intellectual Disabilities. Int. J. Environ. Res. Public Health, 14.","DOI":"10.3390\/ijerph14121503"},{"key":"ref_79","first-page":"23","article-title":"Global Trends in Insufficient Physical Activity among Adolescents: A Pooled Analysis of 298 Population-Based Surveys with 1.6 Million Participants","volume":"4","author":"Guthold","year":"2020","journal-title":"Yearb. Paediatr. Endocrinol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/j.1365-2788.2011.01425.x","article-title":"Identifying the Barriers and Facilitators to Participation in Physical Activity for Children with down Syndrome","volume":"55","author":"Barr","year":"2011","journal-title":"J. Intellect. Disabil. Res."},{"key":"ref_81","first-page":"65","article-title":"Pulmonary Complications in Children with down Syndrome: A Scoping Review","volume":"40","author":"Ides","year":"2021","journal-title":"Paediatr. Respir. Rev."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ridd.2017.12.007","article-title":"Parental Perceptions of Facilitators and Barriers to Physical Activity for Children with Intellectual Disabilities: A Mixed Methods Systematic Review","volume":"73","author":"McGarty","year":"2018","journal-title":"Res. Dev. Disabil."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"e20160541","DOI":"10.1542\/peds.2016-0541","article-title":"Body Composition and BMI Growth Charts in Children with down Syndrome","volume":"138","author":"Zemel","year":"2016","journal-title":"Pediatrics"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2333794X1983564","DOI":"10.1177\/2333794X19835640","article-title":"Trends in Obesity and Overweight in Oregon Children with down Syndrome","volume":"6","author":"Pierce","year":"2019","journal-title":"Glob. Pediatr. Health"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1515\/jpem-2021-0324","article-title":"Serum Adiponectin, Body Adiposity and Metabolic Parameters in Obese Egyptian Children with down Syndrome","volume":"34","author":"Yahia","year":"2021","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"928151","DOI":"10.3389\/fendo.2022.928151","article-title":"The Best Tool for the Assessment of Developmental Disorders in Children with down Syndrome: Comparison of Standard and Specialized Growth Charts-Cross Sectional Study","volume":"13","author":"Hetman","year":"2022","journal-title":"Front. Endocrinol."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Wernio, E., K\u0142osowska, A., Kuchta, A., \u0106wikli\u0144ska, A., Sa\u0142aga-Zaleska, K., Jankowski, M., K\u0142osowski, P., Wi\u015bniewski, P., Wierzba, J., and Ma\u0142gorzewicz, S. (2022). Analysis of Dietary Habits and Nutritional Status of Children with down Syndrome in the Context of Lipid and Oxidative Stress Parameters. Nutrients, 14.","DOI":"10.3390\/nu14122390"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Haligheri, G., Johnson, T., Kathol, M., Kuzava, L., Goth, N., Staggs, V.S., Donnelly, J.E., Ptomey, L.T., and Forsha, D. (2022). Early Cardiac Dysfunction in Obese Adolescents with down Syndrome or Autism. Cardiol. Young, 1\u20138.","DOI":"10.1017\/S1047951122003158"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jpeds.2016.02.046","article-title":"Retrospective Study of Obesity in Children with down Syndrome","volume":"173","author":"Basil","year":"2016","journal-title":"J. Pediatr."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1080\/09637486.2022.2104227","article-title":"Mediterranean Diet and Physical Activity in down Syndrome Pediatric Subjects: The DONUT STUDY","volume":"73","author":"Pecoraro","year":"2022","journal-title":"Int. J. Food Sci. Nutr."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/jir.12933","article-title":"Physical Activity, Sedentary Behaviour and Screen Time among Youths with down Syndrome during the COVID-19 Pandemic","volume":"66","author":"Amatori","year":"2022","journal-title":"J. Intellect. Disabil. Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"641112","DOI":"10.3389\/fnut.2021.641112","article-title":"Eating and Lifestyle Habits in Youth with down Syndrome Attending a Care Program: An Exploratory Lesson for Future Improvements","volume":"8","author":"Roccatello","year":"2021","journal-title":"Front. Nutr."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1080\/13668250600999186","article-title":"Young People with down Syndrome: A Preliminary Investigation of Health Knowledge and Associated Behaviours","volume":"31","author":"Jobling","year":"2006","journal-title":"J. Intellect. Dev. Disabil."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Naczk, A., Gajewska, E., and Naczk, M. (2021). Effectiveness of Swimming Program in Adolescents with down Syndrome. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph18147441"},{"key":"ref_95","first-page":"S76","article-title":"2013 AHA\/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk","volume":"129","author":"Eckel","year":"2013","journal-title":"Circulation"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4278\/ajhp.140213-QUAN-71","article-title":"Association of Concurrent Healthy Eating and Regular Physical Activity with Cardiovascular Disease Risk Factors in U.S. Youth","volume":"30","author":"Loprinzi","year":"2015","journal-title":"Am. J. Health Promot. AJHP"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"e12984","DOI":"10.1111\/mcn.12984","article-title":"Breastfeeding and Childhood Obesity: A 12-Country Study","volume":"16","author":"Ma","year":"2020","journal-title":"Matern. Child Nutr."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1177\/1744629520970078","article-title":"Down Syndrome and Breastfeeding: A Systematic Review","volume":"26","author":"Magenis","year":"2020","journal-title":"J. Intellect. Disabil."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1146\/annurev-biochem-061516-045037","article-title":"Oxidative Stress","volume":"86","author":"Sies","year":"2017","journal-title":"Annu. Rev. Biochem."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1600-0838.2010.01153.x","article-title":"Aerobic Training at Moderate Intensity Reduced Protein Oxidation in Adolescents with down Syndrome","volume":"22","author":"Ordonez","year":"2010","journal-title":"Scand. J. Med. Sci. Sport."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jsams.2017.10.015","article-title":"What Effect Does Regular Exercise Have on Oxidative Stress in People with down Syndrome? A Systematic Review with Meta-Analyses","volume":"21","author":"Shields","year":"2018","journal-title":"J. Sci. Med. Sport"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"456","DOI":"10.4239\/wjd.v6.i3.456","article-title":"Oxidative Stress, Insulin Resistance, Dyslipidemia and Type 2 Diabetes Mellitus","volume":"6","author":"Tangvarasittichai","year":"2015","journal-title":"World J. Diabetes"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.amjcard.2004.04.047","article-title":"Endothelial Cell Function in Patients with Down\u2019s Syndrome","volume":"94","author":"Santoro","year":"2004","journal-title":"Am. J. Cardiol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/HJR.0b013e3282f2bff3","article-title":"Oxidative Stress and Metabolism at Rest and during Exercise in Persons with down Syndrome","volume":"15","author":"Flore","year":"2008","journal-title":"Eur. J. Cardiovasc. Prev. Rehabil."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0165-3806(84)90060-9","article-title":"Superoxide Dismutase, Glutathione Peroxidase and Lipoperoxidation in Oown\u2019s Syndrome Fetal Brain","volume":"16","author":"Brooksbank","year":"1984","journal-title":"Dev. Brain Res."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"8044","DOI":"10.1073\/pnas.84.22.8044","article-title":"Transgenic Mice with Increased Cu\/Zn-Superoxide Dismutase Activity: Animal Model of Dosage Effects in down Syndrome","volume":"84","author":"Epstein","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10522-006-9002-5","article-title":"Multiple Evidence for an Early Age Pro-Oxidant State in down Syndrome Patients","volume":"7","author":"Degan","year":"2006","journal-title":"Biogerontology"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1084\/jem.137.2.317","article-title":"The Linkage of Genes for the Human Interferon-Induced Antiviral Protein and Indophenol Oxidase-B Traits to Chromosome G-21","volume":"137","author":"Tan","year":"1973","journal-title":"J. Exp. Med."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0748-5514(85)90140-0","article-title":"Free Radicals in Biology and Medicine","volume":"1","author":"Halliwell","year":"1985","journal-title":"J. Free Radic. Biol. Med."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"48389","DOI":"10.1074\/jbc.M409935200","article-title":"A Lipid Peroxidation-Derived Inflammatory Mediator","volume":"279","author":"Kumagai","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"535","DOI":"10.33549\/physiolres.932722","article-title":"Oxidative Stress and down Syndrome. Do Antioxidants Play a Role in Therapy?","volume":"63","author":"Muchova","year":"2014","journal-title":"Physiol. Res."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1011-1344(00)00065-8","article-title":"Signaling Pathways in Cell Death and Survival after Photodynamic Therapy","volume":"57","author":"Moor","year":"2000","journal-title":"J. Photochem. Photobiol. B Biol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s00702-007-0656-1","article-title":"Plasma Amino Acids and Neopterin in Healthy Persons with Down\u2019s Syndrome","volume":"114","author":"Coppus","year":"2007","journal-title":"J. Neural Transm."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/gim.2013.157","article-title":"Phenylalanine Hydroxylase Deficiency: Diagnosis and Management Guideline","volume":"16","author":"Vockley","year":"2013","journal-title":"Genet. Med."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.ridd.2012.12.006","article-title":"Physical Activity, Dietary Habits and Overall Health in Overweight and Obese Children and Youth with Intellectual Disability or Autism","volume":"34","author":"Hinckson","year":"2013","journal-title":"Res. Dev. Disabil."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"e00337","DOI":"10.1002\/edm2.337","article-title":"Thyroid Abnormalities in Children with down Syndrome at St. Paul\u2019s Hospital Millennium Medical College, Ethiopia","volume":"5","author":"Mulu","year":"2022","journal-title":"Endocrinol. Diabetes Metab."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1210\/js.2016-1042","article-title":"Down Syndrome-Associated Diabetes Is Not due to a Congenital Deficiency in \u03b2 Cells","volume":"1","author":"Butler","year":"2017","journal-title":"J. Endocr. Soc."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Moreau, M., Benhaddou, S., Dard, R., Tolu, S., Hamz\u00e9, R., Vialard, F., Movassat, J., and Janel, N. (2021). Metabolic Diseases and down Syndrome: How Are They Linked Together?. Biomedicines, 9.","DOI":"10.3390\/biomedicines9020221"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"15","DOI":"10.6065\/apem.2142236.118","article-title":"Endocrinal Dysfunction in Children with down Syndrome","volume":"27","author":"Metwalley","year":"2022","journal-title":"Ann. Pediatr. Endocrinol. Metab."},{"key":"ref_120","first-page":"70","article-title":"Prevalence of Endocrine Disorders among 6078 Individuals with down Syndrome in the United States","volume":"9","author":"Rivelli","year":"2022","journal-title":"J. Patient-Cent. Res. Rev."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1152\/physrev.00030.2013","article-title":"Thyroid Hormone Regulation of Metabolism","volume":"94","author":"Mullur","year":"2014","journal-title":"Physiol. Rev."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1136\/adc.79.3.242","article-title":"Thyroid Dysfunction in Down\u2019s Syndrome: Relation to Age and Thyroid Autoimmunity","volume":"79","author":"Karlsson","year":"1998","journal-title":"Arch. Dis. Child."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.2337\/dc22-0482","article-title":"Diabetes and Obesity in down Syndrome across the Lifespan: A Retrospective Cohort Study Using U.K. Electronic Health Records","volume":"45","author":"Aslam","year":"2022","journal-title":"Diabetes Care"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/adc.74.4.347","article-title":"Amino Acid Profile in Down\u2019s Syndrome","volume":"74","author":"Heggarty","year":"1996","journal-title":"Arch. Dis. Child."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1002\/mnfr.201200162","article-title":"Blood Biomarkers of Methylation in down Syndrome and Metabolic Simulations Using a Mathematical Model","volume":"56","author":"Obeid","year":"2012","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1038\/s41598-018-20834-y","article-title":"Plasma and Urinary Metabolomic Profiles of down Syndrome Correlate with Alteration of Mitochondrial Metabolism","volume":"8","author":"Caracausi","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0929-693X(97)88974-9","article-title":"Variation Des Acides Amin\u00e9s En Fonction de l\u2019\u00c2ge Chez Des Sujets Trisomiques 21","volume":"4","author":"Mircher","year":"1997","journal-title":"Arch. P\u00e9diatrie"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/s41398-019-0578-3","article-title":"Metabolomics Analysis of Children with Autism, Idiopathic-Developmental Delays, and down Syndrome","volume":"9","author":"Orozco","year":"2019","journal-title":"Transl. Psychiatry"}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/12\/3219\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:39:37Z","timestamp":1760146777000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/12\/3219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,12]]},"references-count":128,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["biomedicines10123219"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines10123219","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,12]]}}}